What We Learned at the ADA Scientific Sessions

We’re talking highlights from the ADA Scientific Sessions! As one of the biggest medical diabetes conferences of the the year, this event brings together thousands of experts, clinicians, and researchers to talk about the most exciting data and developments that have happened over the last year. And we’re breaking down what you need to know. Tune in to hear about the latest cutting-edge research in diabetes treatments and how they could affect your management.Questions We’ll Cover in This Episode: What is new with GLP-1 drugs? Can you prevent type 1 diabetes?  What is going on with once-weekly basal insulin?  How should you set a target for LDL cholesterol? How have the targets changed over the years? How do doctors measure and monitor kidney disease? What is happening with non-insulin therapies for type 1 diabetes?  Show notes
ONE 2023 - https://events.blackthorn.io/e....n/36jDRT6/g/TCOYDCal - https://diatribe.org/JEREMY PETTUS, MD
Associate Professor, University of California, San Diego Health Systems; Director, Type 1 Track & CME, TCOYD; Co-Creator of We Are One DiabetesEUGENE WRIGHT, MD
Medical Director, Performance Improvement; Charlotte Area Health Education Center (AHEC)JOHN B. BUSE, MD, PhD
Verne S. Caviness Distinguished Professor; Director, Diabetes Center; Director, NC Translational and Clinical Sciences Institute; Senior Associate Dean, Clinical Research; University of North Carolina School of MedicineATHENA PHILIS-TSIMIKAS, MD
Corporate VP, Scripps Whittier Diabetes Institute; Director of Community Engagement, Clinical Translational Science Award, Scripps Research Translational Institute; Co-Leader, Scripps Ambulatory Health Equity Council; Associate Clinical Professor of Medicine (voluntary), UCSDJUAN PABLO FRIAS, MD
Medical Director and Principal Investigator, Velocity Clinical Research, Los Angeles; Assistant Clinical Professor of Medicine, UCSD
★ Support this podcast ★